Showing results 4 to 8 of 8
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
2019 | |||
Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial Proceeding/Conference:San Antonio Breast Cancer Congress (SABCS) | 2017 | ||
Saura, COliveira, MFeng, YHDai, MSChen, SWHurvitz, SAKim, SBMoy, BDelaloge, SGradishar, WMasuda, NPalacova, MTrudeau, MEMattson, JYap, YSV, MFDe Laurentiis, MYeh, YMChang, HTYau, TWildiers, HHaley, BFagnani, DLu, YSCrown, JLin, JTakahashi, MTakano, TYamaguchi, MFujii, TYao, BBebchuk, JKeyvanjah, KBryce, RBrufsky, AThe NALA Investigators | 2020 | ||
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: a report of 6 cases from SOLAR-1 Proceeding/Conference:Annals of Oncology | 2020 | ||
Upregulation of Immune Response Biomarkers by Ribociclib Plus Endocrine Therapy in Paired Tumor Samples From Phase I Studies Proceeding/Conference:San Antonio Breast Cancer Symposium 2021 | 2021 |